...
首页> 外文期刊>Journal of Clinical Microbiology >Human Papillomavirus Load Measured by Linear Array Correlates with Quantitative PCR in Cervical Cytology Specimens
【24h】

Human Papillomavirus Load Measured by Linear Array Correlates with Quantitative PCR in Cervical Cytology Specimens

机译:线性阵列测量的人乳头瘤病毒载量与宫颈细胞学标本中的定量PCR相关

获取原文
           

摘要

Carcinogenic human papillomavirus (HPV) infections are necessary causes of most anogenital cancers. Viral load has been proposed as a marker for progression to cancer precursors but has been confirmed only for HPV16. Challenges in studying viral load are related to the lack of validated assays for a large number of genotypes. We compared viral load measured by Linear Array (LA) HPV genotyping with the gold standard, quantitative PCR (Q-PCR). LA genotyping and Q-PCR were performed in 143 cytology specimens from women referred to colposcopy. LA signal strength was measured by densitometry. Correlation coefficients and receiver operating characteristic (ROC) analyses were used to evaluate analytical and clinical performance. We observed a moderate to strong correlation between the two quantitative viral load measurements, ranging from an R value of 0.61 for HPV31 to an R value of 0.86 for HPV52. We also observed agreement between visual LA signal strength evaluation and Q-PCR. Both quantifications agreed on the disease stages with highest viral load, which varied by type (cervical intraepithelial neoplasia grade 2 [CIN2] for HPV52, CIN3 for HPV16 and HPV33, and cancer for HPV18 and HPV31). The area under the curve (AUC) for HPV16 Q-PCR at the CIN3 cutoff was 0.72 (P = 0.004), and the AUC for HPV18 LA at the CIN2 cutoff was 0.78 (P = 0.04). Quantification of LA signals correlates with the current gold standard for viral load, Q-PCR. Analyses of viral load need to address multiple infections and type attribution to evaluate whether viral load has clinical value beyond the established HPV16 finding. Our findings support conducting comprehensive studies of viral load and cervical cancer precursors using quantitative LA genotyping data.
机译:致癌性人乳头瘤病毒(HPV)感染是大多数肛门生殖器癌的必要原因。病毒载量已被提议作为癌症前体进展的标志物,但仅在HPV16中被证实。研究病毒载量的挑战与缺乏针对大量基因型的经过验证的检测方法有关。我们将通过线性阵列(LA)HPV基因分型法测定的病毒载量与金标准定量PCR(Q-PCR)进行了比较。在143例女性阴道镜检查细胞学标本中进行了LA基因分型和Q-PCR。 LA信号强度通过光密度测定法测量。相关系数和接收器工作特性(ROC)分析用于评估分析和临床表现。我们观察到两次定量病毒载量测量之间存在中等至强相关性,从HPV31的 R 值到HPV52的 R 值0.86。我们还观察到视觉LA信号强度评估与Q-PCR之间的一致性。两种定量方法均符合病毒载量最高的疾病阶段,因疾病类型而异(HPV52为宫颈上皮内瘤样变2级[CIN2],HPV16和HPV33为CIN3,HPV18和HPV31为癌症)。在CIN3截止时HPV16 Q-PCR的曲线下面积(AUC)为0.72( P = 0.004),在CIN2截止时HPV18 LA的AUC为0.78( P < / em> = 0.04)。 LA信号的定量与当前病毒载量金标准Q-PCR相关。病毒载量分析需要解决多种感染和类型归因,以评估病毒载量是否具有超出既定HPV16发现的临床价值。我们的研究结果支持使用定量LA基因分型数据对病毒载量和宫颈癌前体进行全面研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号